Primary hyperparathyroidism and ALS is there a relation?

Neurology

Volumn 50, Issue 6, 1998, Pages 1795-1799

  Jackson, Carlayne E ^a   Amato, A A ^a   Bryan, W W ^b   Wolfe, G I ^b   Sakhaee, K ^b   Barohn, R J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; PARATHYROID HORMONE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; PARATHYROID ADENOMA; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

EID: 0031776448     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.6.1795     Document Type: Article

References (26)

1. Hirschberg K. Qur kenntnisse der osseomalacie und ostitis malacissans. Beitr Pathol 1889;6:513-524.
2. Von Recklinghausen F. Die fibrose oder deformier-ende ostitis, die osteomalacie und osteoplastische carcinose in ihren gegensetigen beziehungen. Frestscht Rudolph Virchow zu Seinem 71. Gegurtstag. Berlin: G. Reimer, 1891:1-89.
3. Vicale CT. The diagnostic features of a muscular syndrome resulting from hyperparathyroidism, osteomalacia, owing to renal tubular acidosis, and perhaps to related disorders of calcium metabolism. Trans Am Neurol Assoc 1949;74:143-147.
4. Patten BM, Engel WK. Phosphate and parathyroid disorders associated with the syndrome of amyotrophic lateral sclerosis. In: Rowland LP, ed. Human motor neuron disorders. New York: Raven Press, 1982:181-200.
5. Brooks B. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107.
6. Ross MA, Miller RG, Berchert L, et al. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. Neurology 1998 (in press).
7. Medical Research Council. Aids in the examination of the peripheral nervous system. London: Bailliere Tindall, 1986.
8. Patten BM, Bilezikian JP, Mallette LE, Prince A, Engel WK, Aurbach GD. Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med 1974;80:182-193.
9. Carnevale V, Minisola S, Romagnoli E, et al. Concurrent improvement of neuromuscular and skeletal involvement following surgery for primary hyperparathyroidism. J Neurol 1992; 239:57. Letter.
10. Thomas P, Lebrun C. Progressive spastic paraparesis revealing primary hyperparathyroidism. Neurology 1994;44:178-179.
11. Berenbaum F, Rajzbaum G, Bonnchon P, Amor B. Une hyperparathyroide revelee une chute del la tete. Rev Rhum Mal Osteoartic 1993;60:467-469.
12. Gentric A, Pennec YL. Fatal primary hyperparathyroidism with myopathy involving respiratory muscles. J Am Geriatr Soc 1994;42:1306. Letter.
13. Turken SA, Cafferty M, Silverberg SJ, et al. Neuromuscular involvement in mild, asymptomatic, primary hyperparathyroidism. Am J Med 1989;87:553-557.
14. Garber AJ. Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. J Clin Invest 1983;71:1806-1821.
15. Baczynski R, Massry SG, Magott M, El-Belbessi S, Kohan R, Brantbar N. Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int 1985;28:722-727.
16. Kissel JT, Mendell JR. The endocrine myopathies. In: Rowland LP, DiMauro S, eds. Handbook of clinical neurology. Vol. 18. Myopathies. Amsterdam: Elsevier Science, 1992:538-541.
17. Kaminski HJ, Ruff RL. Congenital disorders of neuromuscular transmission. Hosp Pract 1992;27(9):73-81, 85.
18. Frame B, Heinze EG, Block MA, Manson GA. Myopathy in primary hyperparathyroidism: observations in three patients. Ann Intern Med 1968;68:1022-1027.
19. Smith R, Stern G. Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci 1969;8:511-520.
20. Ljunghall S, Hellman P, Rastad J, Akerstrom G. Primary hyperparathyroidism: epidemiology, diagnosis, and clinical picture. World J Surg 1991;15:681-687.
21. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and economic impact in a community. N Engl J Med 1980;302:189-193.
22. Boonstra CE, Jackson CE. Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients. Am J Clin Pathol 1971;55:523-526.
23. Keating FR, Jones JD, Elveback LR. Distribution of serum calcium and phosphorus values in unselected ambulatory patients. J Lab Clin Med 1969;74:507-514.
24. Christensson T. Familial hyperparathyroidism. Ann Intern Med 1976;85:614-615. Letter.
25. Brooks BR. Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin 1996;14:399-420.
26. Brown RH. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995;80:687-692.